Kumar Neil 的 Form 4 申報
BridgeBio Pharma, Inc.（BBIO），2025/7/3 申報
- 申報編號
- 0000950170-25-093907
- 申報時間
- 2025/7/3
- 交易日
- 2025/7/1-7/2
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $341.1 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Kumar NeilCIK 0001742485 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/7/1 | Common Stock | S賣出處分 | −18,300 | $42.50F2 | −$777,750 | 4,780,147 | 間接 | |
| 2025/7/1 | Common Stock | S賣出處分 | −1,700 | $42.88F4 | −$72,896 | 4,778,447 | 間接 | |
| 2025/7/2 | Common Stock | S賣出處分 | −20,000 | $42.73F5 | −$854,600 | 4,758,447 | 間接 | |
| 2025/7/1 | Common Stock | S賣出處分 | −18,400 | $42.51F6 | −$782,184 | 977,286 | 間接 | |
| 2025/7/1 | Common Stock | S賣出處分 | −1,600 | $42.89F7 | −$68,624 | 975,686 | 間接 | |
| 2025/7/2 | Common Stock | S賣出處分 | −20,000 | $42.73F8 | −$854,600 | 955,686 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents the weighted average sale price of the shares sold from $41.80 to $42.79 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents the weighted average sale price of the shares sold from $42.81 to $42.96 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents the weighted average sale price of the shares sold from $42.145 to $43.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents the weighted average sale price of the shares sold from $41.81 to $42.80 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents the weighted average sale price of the shares sold from $42.81 to $42.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents the weighted average sale price of the shares sold from $42.22 to $43.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。